Clinical Trials Insight: 700028212
Latest Information Update: 13 Mar 2024
At a glance
- Drugs Agatolimod (Primary) ; Tremelimumab (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- Sponsors Coley Pharmaceutical GmbH
Latest Information Update: 13 Mar 2024